RFK Jr. Predicts Psychedelic Therapy for Veterans Within a Year Under Trump

Health Secretary Robert F. Kennedy Jr. is fast-tracking a plan to get psychedelic-assisted therapy to military veterans in record time. During a recent House committee meeting, RFK Jr. laid out an ambitious 12-month goal for the FDA and VA to provide legal access to these breakthrough treatments. With 11 clinical trials already moving at the VA and a "direct liaison" set up to coordinate the effort, the administration is focusing on using substances like MDMA and psilocybin to help heroes struggling with PTSD and depression.

This is a massive win for the broader plant-medicine community. Seeing high-level officials acknowledge that traditional pharma is failing and that "science-based" psychedelic access is the answer helps normalize the entire movement. For regular tokers, this shift toward natural alternatives signals a more open-minded federal approach that could eventually bleed into better cannabis policies. It’s exciting to see the government finally catching up to what the community has known for years: these substances have life-saving potential when handled with respect.